Cost-Effectiveness and Budget-Impact Analysis of Braf Inhibitors in Patients With Metastatic Malignant Melanoma (MMM) in Slovenia
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2216
https://www.valueinhealthjournal.com/article/S1098-3015(14)04146-1/fulltext
Title :
Cost-Effectiveness and Budget-Impact Analysis of Braf Inhibitors in Patients With Metastatic Malignant Melanoma (MMM) in Slovenia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04146-1&doi=10.1016/j.jval.2014.08.2216
First page :
A623
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1669